• FirefoxInstall the new Firefox »
  •  Dow Down 0.47% Nasdaq Down 0.56%

    ZIOPHARM Oncology, Inc. (ZIOP)

    -NasdaqCM
    12.49 Up 0.70(5.94%) 4:00PM EST
    |After Hours : 12.40 Down 0.09 (0.72%) 6:08PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:11.79
    Open:12.14
    Bid:12.40 x 2000
    Ask:12.48 x 2000
    1y Target Est:13.67
    Beta:0.49
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:11.60 - 12.60
    52wk Range:2.31 - 12.60
    Volume:6,169,181
    Avg Vol (3m):3,516,140
    Market Cap:1.30B
    P/E (ttm):N/A
    EPS (ttm):-0.31
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ZIOPUp 5.94%1.30B
    IMGNDown 4.44%649.25M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):895.69
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.54
    Quarterly EPS Est (Mar-15) :-0.13
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ZIOPHARM Oncology, Inc., a biotechnology company, engages in the discovery and development of cancer therapies. The company is employing novel gene expression and control technology to deliver DNA for the treatment of cancer. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback